Literature DB >> 6408172

A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8.

B Perussia, V Fanning, G Trinchieri.   

Abstract

The antigen recognized by monoclonal antibody OKT8 is expressed on the cell membrane of 30 to 50% of human NK/K cells. The reactivity of OKT8 with NK/K cells was determined by indirect methods (treatment of the effector cells with OKT8 antibody and complement (C) and separation of OKT8(+) and (-) effector cell populations by fluorescence-activated cell sorting or by rosetting techniques) and, at single cell level, by C-dependent lysis of effector NK cells that bind and kill K562 targets. Analysis by indirect immunofluorescence (flow cytofluorometry) of lymphocyte subpopulations mediating NK/K cytotoxic activity and deprived of OKT8(+) T cells reveals that the NK/K cell subset bears OKT8 antigen at a density lower than that present on cytotoxic T cells. The OKT8 antigen on NK/K cells is trypsin- and pronase-sensitive, but it is resynthesized by the same effector cells during 24 hr of culture at 37 degrees C. OKT8 antibody does not inhibit NK killing, and, on a per cell basis, OKT8(+) cells within the NK/K subset mediate the same level of cytotoxic activity as OKT8(-) NK/K cells. Analogous results were obtained by using anti-Leu-2a, an antibody with the same specificity as OKT8 on cytotoxic/suppressor T cells, but not when OKT5 was used, which might identify a distinct epitope on the same antigenic molecule. The possible significance of these findings in understanding the cell lineage of NK/K cells is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6408172

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  Functional surface structures on human natural killer cells.

Authors:  R E Schmidt; T Hercend; S F Schlossman; J Ritz
Journal:  Klin Wochenschr       Date:  1985-12-02

2.  Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer.

Authors:  T A Zikos; A D Donnenberg; R J Landreneau; J D Luketich; V S Donnenberg
Journal:  Cancer Immunol Immunother       Date:  2011-03-05       Impact factor: 6.968

3.  Synergism in the activation of human CD8 T cells by cross-linking the T-cell receptor complex with the CD8 differentiation antigen.

Authors:  F Emmrich; U Strittmatter; K Eichmann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

4.  Natural killer activity in patients with chronic hepatitis treated with OK432, interferon, adenine arabinoside and glycyrrhizin.

Authors:  T Wada; T Arima; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1987-06

5.  The influence of cytomegalovirus carrier status on lymphocyte subsets and natural immunity.

Authors:  J W Gratama; M Kardol; A M Naipal; J Slats; A Den Ouden; T Stijnen; J D'Amaro; T H The; J W Bruning
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

6.  Expression of T-cell associated antigens by porcine natural killer cells.

Authors:  M D Pescovitz; M A Lowman; D H Sachs
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

7.  Abnormal patterns of equine leucocyte differentiation antigen expression in severe combined immunodeficiency foals suggests the phenotype of normal equine natural killer cells.

Authors:  D P Lunn; J T McClure; C S Schobert; M A Holmes
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

8.  Natural killing and growth inhibition of K562 cells by subpopulations of mononuclear cells as a function of target cell proliferation.

Authors:  G Hagner
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

9.  The role of lymphocyte surface binding sites for wheat germ agglutinin in the negative regulation of cancer patients.

Authors:  T Toge; Y Yamaguchi; A Sawamura
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

10.  Cytotoxic T lymphocyte activity to hepatitis B virus DNA-transfected HepG2 cells in patients with chronic hepatitis B.

Authors:  Y Ito; S Kakumu; K Yoshioka; T Wakita; T Ishikawa; K Koike
Journal:  Gastroenterol Jpn       Date:  1993-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.